MERCK's U.S. BUSINESS PASSES $ 4 BIL. IN 1990; SCHERING's NET PROFIT MARGINS CLIMB OVER 17% IN STRONG YEAR-END; PROTROPIN MAKES $ 157 MIL. FOR GENENTECH

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".